← All stocks

Upstream Bio, Inc.

UPB No buying or selling

CIK 0002022626 #3343 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

9 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

AI Upstream LLC entity

10% owner

—

5,494,410

$33.52M

—

ORBIMED ADVISORS LLC entity

Director

—

4,554,873

$27.78M

+3,693%

Chimovits Erez

Director

—

4,554,873

$27.78M

+3,693%

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

10% owner

—

894,733

$5.46M

—

Sutherland Everett Rand

Chief Executive Officer

—

70,812

$431.95K

—

Deykin Aaron

Chief Medical Officer

—

33,197

$202.50K

+1,012%

GRAY MICHAEL

CFO and COO

—

28,795

$175.65K

—

Houghton Adam

Chief Business Officer

—

23,601

$143.97K

—

Ambrose Allison

General Counsel

—

16,048

$97.89K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 15 Oct 2024